| Line Item | 2025-09-05 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $24K | — | — |
| SG&A Expense | $2.4M | — | — |
| Operating Income | -$3.3M | — | — |
| Net Income | $2.8M | — | — |
| EPS (Basic) | $0.13 | — | — |
| EPS (Diluted) | $0.13 | — | — |
| Line Item | 2025-09-05 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $625K | — | — |
| Current Assets | $800K | — | — |
| Total Assets | $7.0M | — | — |
| Current Liabilities | $19.7M | — | — |
| Total Liabilities | $20.0M | — | — |
| Stockholders' Equity | -$13.0M |
| Line Item | 2025-09-05 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$1.3M | — | — |
| Investing Cash Flow | $545K | — | — |
| Financing Cash Flow | $1.3M | — | — |
| — |